cBIN1 gene therapy (TikkunLev Therapeutics/University of Utah)

N/A

Report date: 2023/12/15 14:23:59

Base Information

Drug NamecBIN1 gene therapy (TikkunLev Therapeutics/University of Utah)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of UtahTikkunLev Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesTikkunLev TherapeuticsThe University Of Utah
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A